Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Heparegenix identifies new MAPKK 4 inhibitors

Aug. 9, 2021

Prometheus initiates phase IIa APOLLO-CD study of PRA-023 in Crohn's disease

Aug. 3, 2021

TVB-2640 shows promising efficacy in phase II FASCINATE-1 study in patients with NASH

July 30, 2021

Positive phase II data for LB-1148 in patients undergoing gastrointestinal surgery

July 30, 2021

Vonafexor meets primary endpoint in the phase IIa LIVIFY study in patients with NASH

July 29, 2021

Eccogene begins first-in-human study of ECC-0509 for NASH and osteoarthritis pain

July 28, 2021

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Cerecor reports initial phase Ib data on CERC-002 in moderate to severe Crohn's disease

July 27, 2021

New DGAT-2 inhibitors discovered at LG Chem

July 27, 2021

Enteric HDL shown to prevent liver injury via portal vein

July 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...